[attention] more than 50 executives of Listed Companies in the pharmaceutical industry resigned!

From 2018 to now, the pharmaceutical industry has been in a dark tide, and the personnel changes of pharmaceutical enterprises are unpredictable According to incomplete statistics, more than 50 senior managers of pharmaceutical companies have resigned since last year The following contents are from the enterprise announcement and presented in chronological order Details of resignation of senior executives of pharmaceutical enterprises (statistical time: 2018 to now) announcement date: January 3, 2019 Mr Ye cunxiao, vice president of Zhejiang Huahai Pharmaceutical Co., Ltd., applied to resign as vice president of the company due to personal reasons Announcement date: on January 2, 2019, Mr Guan Yanbin, chairman and general manager of sunflower Pharmaceutical Group Co., Ltd., due to his age, applied to resign from the position of director, chairman and general manager of the third board of directors of the company, and at the same time resigned from the position of member of the strategy committee of the third board of directors After resigning, Mr Guan Yanbin still served as the director of the company's Strategic Advisory Committee Date of announcement: December 28, 2018 the board of directors of Shenzhen Huada gene Co., Ltd recently received an application from Mr Zhang Ling, the chief operating officer of the company, to resign from the post of chief operating officer of the company due to personal reasons After resignation, he will not hold any post in the company Announcement date: on December 29, 2018, Mr Yao Xingtian of Jiangsu Lianhuan Pharmaceutical Co., Ltd applied to resign from the position of chairman, director and strategic committee of the company due to his retirement age Date of announcement: on December 28, 2018, Mr Wu Jiangang, deputy chairman, Secretary of the board of directors and deputy general manager of Hangzhou Tianmushan Pharmaceutical Co., Ltd., resigned as vice chairman, director, Secretary of the board of directors and deputy general manager of the company due to personal reasons And he will no longer hold other positions in the company after resigning Announcement date: December 27, 2018, written resignation report of Mr Yang Mingjian, deputy general manager of Guizhou shengjitang Pharmaceutical Industry Co., Ltd Mr Yang Mingjian applied to resign from the position of deputy general manager of the company for personal reasons Announcement date: on December 27, 2018, Ms Ai Qing, the securities affairs representative of Kunming Pharmaceutical Group Co., Ltd., made a written resignation report Because the company had another appointment for her, she applied to resign as the securities affairs representative of the company Announcement date: December 27, 2018 Mr Mi Chaojie of Shandong Saito Biotechnology Co., Ltd applied for resigning from the position of chairman and director of the second board of directors of the company due to personal reasons, and also resigned from the position of member of the strategy committee, member of the nomination committee and general manager; Ms Mi Jia applied for resigning from the position of director of the second board of directors of the company due to personal reasons, and resigned from the position of member of the audit committee and member of the strategy committee The above two persons will no longer hold any other positions in the company Date of announcement: on December 18, 2018, Mr Xu Dingbo and Ms Shaorong, independent directors of Shanghai Modern Pharmaceutical Co., Ltd., filed an application for resignation to the board of directors of the company due to the expiration of their term of office, requesting to resign from the position of independent director and corresponding special committee of the board of directors No post will be held in the company after resignation Date of announcement: on December 14, 2018, the board of supervisors of Shanghai Modern Pharmaceutical Co., Ltd received the written resignation report submitted by Mr Yang Wenming, a supervisor of the company, on December 13, 2018 Mr Yang Wenming resigned as a supervisor of the company for work reasons Announcement date: on December 13, 2018, Mr Chen Congming, a director of Nanjing Pharmaceutical Co., Ltd., applied to resign as a director of the eighth board of directors and a member of the audit and risk control committee of the board of directors due to the change of work After resignation, Mr Chen Congming did not hold any post in the company Date of announcement: on December 12, 2018, Mr Zhou Jingbo and Mr Zhao Chenbin, directors of the 8th board of directors of Shanghai first pharmaceutical Co., Ltd., respectively requested to resign from their posts as directors of the 8th board of directors and members of relevant special committees under the board of directors After resignation, he will no longer hold any post in the company Date of announcement: on December 4, 2018, Mr Liu Qun, chairman of Tiansheng Pharmaceutical Group Co., Ltd., was subjected to residential surveillance at designated residence by Chongqing Public Security Bureau due to his suspected duty encroachment crime, unable to perform relevant duties Mr Liu Qun applied for resigning from the post of chairman, director and member of special committee under the board of directors due to his inability to perform relevant duties normally After resigning, he will no longer hold any post in the company Date of announcement: on November 24, 2018, Mr Ding Jingdong of Chongqing pharmaceutical Holding Co., Ltd applied to resign as a director of the company due to his retirement age, and no longer served as a member of the strategy and Investment Committee of the board of directors Date of announcement: on November 21, 2018, Mr Shuai Jinbing, director of Wuhu Huahai Biotechnology Co., Ltd., resigned for personal reasons, and he will no longer hold other positions in the company after resignation Date of announcement: on November 20, 2018, Ms Liu Meijuan and Mr Wang Zhao, independent directors of Yifan Pharmaceutical Co., Ltd., submitted resignation application to the board of directors of the company for six years after the expiration of their term of office After resignation, they will no longer hold any post in the company Date of announcement: on November 9, 2018, the board of directors of Zhejiang Haizheng Pharmaceutical Co., Ltd received the written resignation application submitted by Mr Bai Hua, chairman of the company Due to age and physical reasons, Mr Bai Hua resigned from the position of chairman of the seventh board of directors, director, member of the nomination committee and standing member of the expert committee, and no longer served as the legal representative of the company He will not hold any post in the company after resigning Announcement date: on October 30, 2018, Mr Wang Lifeng, vice president of Shanghai Haili Biotechnology Co., Ltd., submitted a written resignation report Mr Wang Lifeng applied to resign as vice president of the company for personal reasons No longer hold other positions in the company after resignation Date of announcement: on October 26, 2018, Ms Xie Yanyan and Mr Zhou Xiangyang, directors of Huaren Pharmaceutical Co., Ltd applied for resigning their positions as directors, members of the strategy committee and the nomination committee of the board of directors due to their work reasons; after resigning, both of them no longer hold any other positions in the company Announcement date: on October 24, 2018, Mr Feng Yi of China Resources Sanjiu Pharmaceutical Co., Ltd resigned as a supervisor of the seventh board of supervisors due to the change of work content No longer hold any office in the company after resignation Date of announcement: on October 23, 2018, Mr Feng Yi, a supervisor of China Resources Shuanghe Pharmaceutical Co., Ltd., proposed to resign as a supervisor of the 8th board of supervisors due to the change of work content Announcement date: on October 15, 2018, Mr Li Xi, chairman of Zhuhai Rundu Pharmaceutical Co., Ltd., resigned from the post of chairman, director and chairman (convener) of the strategy committee due to personal physical reasons The reasons for his resignation are consistent with the actual situation Date of announcement: on October 13, 2018, Mr Huo Guang, Secretary of the board of directors of Heilongjiang Treasure Island Pharmaceutical Co., Ltd., resigned as secretary of the board of directors due to personal reasons, and will no longer be responsible for the relevant work of the Secretary of the board of directors of the company Announcement date: on October 13, 2018, Mr Feng Yi and Mr Li Shizhong, supervisors of dong'a-jiao Co., Ltd., applied to resign from the position of supervisor of the ninth board of supervisors of the company due to the change of work content, and they will no longer hold any position in the company after resigning Announcement date: resignation report submitted by Mr Wang Tianming, director, deputy general manager and Secretary of the board of directors of Hubei Baker Pharmaceutical Co., Ltd on October 10, 2018 No longer hold other positions in the company after resignation Date of announcement: on October 7, 2018, the board of directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd received an application from Ms Shi Jiajue, vice president, to resign as vice president for personal reasons Announcement date: on August 27, 2018, Li Yinghui, chairman of Runze biology company, resigned as chairman of the board due to personal reasons, and continued to serve as the company's director, general manager, Secretary of the board of directors and legal representative after resignation Date of announcement: on August 9, 2018, Mr Zhang Yongqiang, deputy general manager of Jiangsu Hengrui Pharmaceutical Co., Ltd., applied to resign from the post of deputy general manager of the company due to work reasons Meanwhile, Mr Zhang Yongqiang still holds other positions in the company Date of announcement: on July 6, 2018, the board of directors of Sichuan Kelun Pharmaceutical Co., Ltd received the application of Mr Wei Qingjie, deputy general manager of the company, to resign from the position of deputy general manager of the company due to personal reasons, and he will no longer hold any post in the company after resignation Date of announcement: on June 26, 2018, the board of directors of Harbin Pharmaceutical Group Co., Ltd received the resignation report from Ms Sha Mei, deputy general manager of the company, who resigned from the company's deputy general manager and all other positions of the company due to personal reasons Announcement date: on June 29, 2018, Ms Zhan Xiaozhou, chairman and legal representative of Suzhou southeast Pharmaceutical Co., Ltd., resigned from the position of chairman of the board of directors After resignation, he will continue to be a director of the company Date of announcement: on May 23, 2018, Mr Li Zhongqiu, chairman of Shanghai Johnson & Johnson Holding Co., Ltd., proposed to resign from the board of directors and chairman of the ninth board of directors of the company due to work adjustment Announcement date: on April 17, 2018, Mr Songli, a director of Hangzhou tiger Pharmaceutical Technology Co., Ltd., proposed to resign as a director of the company due to personal reasons Upon resignation, Mr Songli will no longer hold any office in the company Date of announcement: on April 10, 2018, Mr Ge Xiangquan, deputy general manager and Secretary of the board of directors of Puluo Pharmaceutical Co., Ltd., applied to resign from the post of deputy general manager and Secretary of the board of directors due to the change of work, and he will no longer hold any post in the company after resignation Date of announcement: on March 31, 2018, Mr Chen kaihong, Secretary of the board of directors of Peking University Pharmaceutical Co., Ltd., applied to resign as secretary of the board of directors for personal reasons Announcement date: on March 31, 2018, Mr Sun Bing, Secretary of the board of directors and chief financial officer of Shanghai first pharmaceutical Co., Ltd., requested to resign as secretary of the eighth board of directors and chief financial officer of the company due to work transfer After resignation, he will no longer hold any post in the company Date of announcement: on March 31, 2018, Mr Yue Liuzhong, deputy general manager of Shanghai first pharmaceutical Co., Ltd., requested to resign as deputy general manager of the company due to work transfer After resignation, he will no longer hold any post in the company Announcement date: on March 31, 2018, Mr Wang Yawei, director and general manager of Shanghai first pharmaceutical Co., Ltd., resigned from the position of director of the eighth board of directors, member of relevant special committee under the board of directors and general manager due to personal reasons Announcement date: March 31, 2018 Mr Xu guohan, deputy general manager of Yifan Pharmaceutical Co., Ltd applied for resignation as deputy general manager of the company due to work adjustment After resignation, Mr Xu guohan still served as the person in charge of business and bidding affairs of the pharmaceutical preparation sector of the company and was nominated as the supervisor candidate of the 6th supervisory board of the company Mr Zhu Gang applied for resignation as deputy general manager of the company for personal reasons and resigned Served as general consultant of tumor affairs of the company Announcement date: on March 28, 2018, Mr Zhong Hongguang, chairman of the board of directors of Jiangzhong Pharmaceutical Co., Ltd., resigned as a director, chairman, general manager, convener of the strategic development committee, member of the nomination committee and other positions of the company due to his retirement application After resignation, he will no longer hold any position in the company Date of announcement: on March 27, 2018, Mr fenlaitan, the director, senior vice president and chief medical officer of Beida Pharmaceutical Co., Ltd., applied for resigning as a director, senior vice president and chief medical officer of the company due to personal reasons After resignation, Mr fenlaitan will serve as the company's special consultant and participate in the research and consultation of the company's clinical stage new drug project Announcement date: March 23, 2018: Mr Chen Jian, chairman and general manager of Tianjin TIANYAO Pharmaceutical Co., Ltd., applied to the board of directors of the company for resignation due to the change of work